Signal in for our daily briefing
Make your busy days more handy with Axios AM/PM. Pick up on what’s original and why it matters in honest 5 minutes.
Pick up on the day’s most animated trade stories
Subscribe to Axios Closer for insights into the day’s trade details and tendencies and why they topic
Protect on high of the most fresh market tendencies
Subscribe to Axios Markets for the most fresh market tendencies and financial insights. Signal in with out cost.
Sports activities details well-known of your time
Binge on the stats and stories that power the sports world with Axios Sports activities. Signal in with out cost.
Tech details well-known of your time
Salvage our honest take on know-how from the Valley and D.C. with Axios Login. Signal in with out cost.
Salvage the interior stories
Salvage an insider’s book to the original White Dwelling with Axios Sneak Scrutinize. Signal in with out cost.
Axios for your phone
Salvage breaking details and scoops on the hotfoot in conjunction with the Axios app.
Procure with out cost.
Pick up on coronavirus stories and particular reports, curated by Mike Allen on an recurring foundation
Pick up on coronavirus stories and particular reports, curated by Mike Allen on an recurring foundation
Desire a daily digest of the cease Denver details?
Salvage a daily digest of essentially the most important stories affecting your fatherland with Axios Denver
Desire a daily digest of the cease Des Moines details?
Salvage a daily digest of essentially the most important stories affecting your fatherland with Axios Des Moines
Desire a daily digest of the cease Twin Cities details?
Salvage a daily digest of essentially the most important stories affecting your fatherland with Axios Twin Cities
Desire a daily digest of the cease Tampa Bay details?
Salvage a daily digest of essentially the most important stories affecting your fatherland with Axios Tampa Bay
Desire a daily digest of the cease Charlotte details?
Salvage a daily digest of essentially the most important stories affecting your fatherland with Axios Charlotte
Signal in for Axios NW Arkansas
Protect up-to-date on essentially the most important and enticing stories affecting NW Arkansas, authored by native newshounds
Declare: Marcos del Mazo/LightRocket by Getty Photos
The U.S. executive has bought an extra 200 million doses of the Pfizer-BioNTech vaccine to be delivered from October 2021 thru April 2022, the companies announced Friday.
Why it matters: The Biden administration is persevering with to make bigger its arsenal of vaccine doses because it seeks to support vaccinate the area and doubtlessly bring booster footage to U.S. residents if it turns into crucial.
- The U.S. has now bought 500 million of the 600 million that that you just would possibly maybe well be factor in doses negotiated between the Trump administration and Pfizer and BioNtech in July 2020.
- The accept is spoil free an agreement announced last month for Pfizer and BioNTech to present the U.S. with 500 million vaccine doses to support vaccinate the area’s poorest countries.
What they’re announcing: The 200 million doses the administration is exercising in its contract is to “put collectively for future vaccination needs, in conjunction with vaccines for children below 12 and that that you just would possibly maybe well be factor in booster footage if reports grunt they’re crucial,” in step with a senior Biden administration official.
Between the lines: The announcement notes that the U.S. has the chance to “make an up to date version of the vaccine to address possible variants to boot to original formulations of the vaccine, if on hand and authorized.”
- Also as part of the agreement, Pfizer will provide the U.S. with 65 million pediatric doses ought to Pfizer’s vaccine be authorized for children below 12.
